Clinical Trials Browser

Phase 1/2 × Leukemia, Myeloid, Acute × Aclarubicin × Clear all

NCT07486726 2026-03-20

Aclarubicin Plus With Azacitidine and Venetoclax in the Treatment of Acute Myeloid Leukemia

Phase 1/2 Not yet recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute